BCAT1 and central nervous system cancer: D-2HG also inhibits the branched-chain amino acid transaminase 1 (BCAT1) and 2 (BCAT2), which renders IDH1 mutant glioma cells dependent on glutaminase and increases their sensitivity to oxidative stress [151].